ClinicalTrials.gov record
Active, not recruiting Phase 1Phase 2 Interventional

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

ClinicalTrials.gov ID: NCT04551131

Public ClinicalTrials.gov record NCT04551131. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 12:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT04551131
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
St. Jude Children's Research Hospital
Other
Enrollment
10 participants

Conditions and interventions

Interventions

  • Dexamethasone Drug
  • Etoposide Drug
  • Ruxolitinib Drug

Drug

Eligibility (public fields only)

Age range
6 Weeks to 22 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 12, 2021
Primary completion
Nov 6, 2025
Completion
Jul 31, 2026
Last update posted
Apr 23, 2026

2021 – 2026

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016
Children's Hospital of Orange County Orange California 92868
University of California San Francisco San Francisco California 94158
Children's National Medical Center Washington D.C. District of Columbia 20010
John Hopkins University Baltimore Maryland 21287
Dana-Farber Cancer Institute Boston Massachusetts 02215
Cohen Children's Medical Center New Hyde Park New York 11040
Levine Children's Hospital Charlotte North Carolina 28203
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
St. Jude Children's Research Hospital Memphis Tennessee 38105
University of Texas Southwestern Medical Center Dallas Texas 75235
Texas Children's Hospital Houston Texas 77030
Children's Wisconsin/Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04551131, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04551131 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →